The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer
T-SPOT.TB yielded more actionable results than QFT-TB in patients with cancer. T-SPOT.TB might be a better IGRA for screening for latent TB infection in patients with cancer, although a direct comparison would be needed to definitively determine this.
Authors
- Georgios Angelidakis (ORCID: https://orcid.org/0000-0001-7855-9670)
- Ella Ariza‐Heredia (ORCID: https://orcid.org/0000-0003-4543-6177)
- Prathit A. Kulkarni (ORCID: https://orcid.org/0000-0001-8611-8699)
- Fareed Khawaja (ORCID: https://orcid.org/0000-0003-4424-283X)
- Joseph Sassine (ORCID: https://orcid.org/0000-0001-8730-8929)
- Joumana Kmeid (ORCID: https://orcid.org/0000-0001-5679-6130)
- Firas El Chaer (ORCID: https://orcid.org/0000-0001-9596-0714)
- Edward A. Graviss (ORCID: https://orcid.org/0000-0003-1024-5813)
- Roy F. Chemaly (ORCID: https://orcid.org/0000-0002-0277-3088)
- Victor E. Mulanovich (ORCID: https://orcid.org/0000-0001-7028-4860)
- Marjorie Vieira Batista (ORCID: https://orcid.org/0000-0003-0717-0873)
Institutions
- University of Maryland, Baltimore (US)
- Houston Methodist (US)
- Michael E. DeBakey VA Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Baylor College of Medicine (US)
- AC Camargo Hospital (BR)
- U-M Rogel Cancer Center (US)
- University of Oklahoma Health Sciences Center (US)
- Lebanese American University (LB)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1111/tid.14428
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00